Literature DB >> 18538787

Autophosphorylated residues involved in the regulation of human chk2 in vitro.

Guillaume Gabant1, Alain Lorphelin, Nathalie Nozerand, Charles Marchetti, Laurent Bellanger, Alain Dedieu, Eric Quéméneur, Béatrice Alpha-Bazin.   

Abstract

Human checkpoint kinase 2 is a major actor in checkpoint activation through phosphorylation by ataxia telangiectasia mutated in response to DNA double-strand breaks. In the absence of de novo DNA damage, its autoactivation, reported in the event of increased Cds1/checkpoint kinase 2 (Chk2) expression, has been attributed to oligomerization. Here we report a study performed on autoactivated recombinant Chk2 proteins that aims to correlate kinase activity and phosphorylation status. Using a fluorescence-based technique to assay human checkpoint kinase 2 catalytic activity, slight differences in the ability to phosphorylate Cdc25C were observed, depending on the recombinant system used. Using mass spectrometry, the phosphorylation sites were mapped to identify sites potentially involved in the kinase activity. Five phosphorylated positions, at Ser120, Ser260, Thr225, Ser379 and Ser435, were found to be common to bacteria and insect cells expression systems. They were present in addition to the six known phosphorylation sites induced by ionizing radiation (Thr68, Thr432, Thr387, Ser516, Ser33/35 and Ser19) detected by immunoblotting. After phosphatase treatment, Chk2 regained activity via autorephosphorylation. The determination of the five common sites and ionizing-radiation-inducible positions as rephosphorylated confirms that they are potential positive regulators of Chk2 kinase activity. For Escherichia coli's most highly phosphorylated 6His-Chk2, 13 additional phosphorylation sites were assigned, including 7 novel sites on top of recently reported phosphorylation sites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538787     DOI: 10.1016/j.jmb.2008.04.053

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

1.  Distinct DNA damage determines differential phosphorylation of Chk2.

Authors:  Mutsuko Ouchi; Toru Ouchi
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

Review 2.  Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response.

Authors:  Travis H Stracker; Takehiko Usui; John H J Petrini
Journal:  DNA Repair (Amst)       Date:  2009-05-26

Review 3.  CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

Authors:  Lenka Stolarova; Petra Kleiblova; Marketa Janatova; Jana Soukupova; Petra Zemankova; Libor Macurek; Zdenek Kleibl
Journal:  Cells       Date:  2020-12-12       Impact factor: 6.600

4.  Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells.

Authors:  Barbora Šalovská; Hana Janečková; Ivo Fabrik; Radana Karlíková; Lucie Čecháková; Martin Ondrej; Marek Link; David Friedecký; Aleš Tichý
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.